Skip to main content
. 2017 Nov 25;8(67):111161–111175. doi: 10.18632/oncotarget.22686

Table 4. Association between RIP140 and LCoR and clinicopathological features in colorectal cancer.

Parameters n (102) RIP140 n (99) LCoR
Low n (%) Moderate n (%) High n (%) Low n (%) Moderate n (%) High n (%)
Gender
Male 47 6(12.8) 16(34) 25(53.2) 45 25(55.6) 8(17.8) 12(26.7)
Female 55 8(14.5) 14(25.5) 33(60) 54 29(53.7) 8(14.8) 17(31.5)
p-value 0.637 0.842
Age
≤60 39 3(7.7) 15(38.5) 21(53.8) 38 19(50) 11(28.9) 8(21.1)
>60 63 11(17.5) 15(23.8) 37(58.7) 61 35(57.4) 5(8.2) 21(34.4)
p-value 0.171 0.019
TNM-stage
I-II 41 2(4.9) 16(39) 23(56.1) 40 23(57.5) 5(12.5) 12(30)
III 42 6(14.3) 10(23.8) 26(61.9) 42 20(47.6) 7(16.7) 15(35.7)
IV 17 6(35.3) 3(17.6) 8(47.1) 17 11(64.7) 4(23.5) 2(11.8)
p-value 0.027 0.4
Tumor site
Colon 65 9(14.1) 16(25) 39(60) 64 38(59.4) 6(9.4) 20(31.3)
Rectum 37 5(13.5) 13(35.1) 19(51.4) 34 15(44.1) 10(29.4) 9(26.5)
p-value 0.544 0.037
Differentiation
Poor 61 6(9.8) 20(32.8) 35(57.4) 60 37(61.7) 8(13.3) 15(25)
Moderate 37 7(18.9) 8(21.6) 23(59.5) 37 17(45.9) 6(16.2) 14(36.8)
Well 2 1(50) 1(50) 0(0) 2 0(0) 2(100) 0(0)
p-value 0.22 0.011
Tumor size
T≤5 cm 53 11(16.4) 20(29.9) 36(53.7) 50 35(54.7) 10(15.6) 19(29.7)
T>5 cm 48 3(8.8) 10(29.4) 21(61.8) 48 19(55.9) 6(17.6) 9(26.5)
p-value 0.549 0.936